PULMONX CORPORATION
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.8M | $20.6M | $22.6M | $21.5M | $23.9M | $22.5M | $23.8M | $20.4M |
| Cost of Revenue | $5.0M | $4.5M | $5.1M | $5.5M | $6.7M | $6.2M | $6.2M | $5.4M |
| Gross Profit | $17.7M | $16.0M | $17.5M | $16.1M | $17.2M | $16.3M | $17.6M | $15.0M |
| Gross Margin | 78.0% | 77.9% | 77.6% | 74.7% | 72.1% | 72.5% | 74.0% | 73.7% |
| Operating Expenses | ||||||||
| Research & Development | $5.0M | $4.9M | $4.6M | $4.8M | $5.3M | $4.8M | $4.0M | $3.7M |
| SG&A Expense | $21.8M | $24.1M | $22.9M | $25.6M | $26.7M | $26.1M | $27.0M | $25.4M |
| Operating Income | $-9.1M | $-13.0M | $-9.9M | $-14.4M | $-14.8M | $-14.6M | $-13.4M | $-14.1M |
| Operating Margin | -39.8% | -62.9% | -43.8% | -66.9% | -62.0% | -64.6% | -56.5% | -69.3% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-9.9M | $-13.5M | $-10.2M | $-13.8M | $-15.0M | $-14.3M | $-13.1M | $-14.0M |
| Income Tax Expense | $133.0K | $149.0K | $186.0K | $128.0K | $177.0K | $135.0K | $38.0K | $192.0K |
| Net Income | $-10.1M | $-13.7M | $-10.4M | $-14.0M | $-15.2M | $-14.4M | $-13.2M | $-14.1M |
| Net Margin | -44.3% | -66.3% | -46.1% | -64.9% | -63.6% | -64.1% | -55.4% | -69.4% |
| EPS (Basic) | $-0.24 | $-0.33 | $-0.25 | $-0.34 | $-0.38 | $-0.36 | $-0.33 | $-0.36 |
| EPS (Diluted) | $-0.24 | $-0.33 | $-0.25 | $-0.34 | $-0.38 | $-0.36 | $-0.33 | $-0.36 |
| Shares Outstanding (Basic) | 42.5M | 41.9M | 40.7M | 40.9M | 40.4M | 40.0M | 39.1M | 39.3M |
| Shares Outstanding (Diluted) | 42.5M | 41.9M | 40.7M | 40.9M | 40.4M | 40.0M | 39.1M | 39.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |